A Rare Opportunity 

Tue, Nov 5th 2019

I attended the NORD 2019 Summit in Washington, DC a few weeks ago. It was my first chance to attend this conference organized by the National Organization for Rare Diseases and, admittedly, the first time I considered going.

Read More

On Novartis' Data Manipulation

Wed, Aug 21st 2019

The news this past week that scientists at Novartis manipulated data in comparability studies for their gene therapy (Zolgensma) was surprising and disheartening. You can read one of the 

Read More